OX40 is required for regulatory T cell-mediated control of colitis
Thibault Griseri, Mark Asquith, Claire Thompson, Fiona Powrie, Thibault Griseri, Mark Asquith, Claire Thompson, Fiona Powrie
Abstract
The immune response in the gastrointestinal tract is a tightly controlled balance between effector and regulatory cell responses. Here, we have investigated the role of OX40 in influencing the balance between conventional T cells and Foxp3+ regulatory T (T reg) cells. Under steady-state conditions, OX40 was required by T reg cells for their accumulation in the colon, but not peripheral lymphoid organs. Strikingly, under inflammatory conditions OX40 played an essential role in T reg cell-mediated suppression of colitis. OX40(-/-) T reg cells showed reduced accumulation in the colon and peripheral lymphoid organs, resulting in their inability to keep pace with the effector response. In the absence of OX40 signaling, T reg cells underwent enhanced activation-induced cell death, indicating that OX40 delivers an important survival signal to T reg cells after activation. As OX40 also promoted the colitogenic Th1 response, its expression on T reg cells may be required for effective competition with OX40-dependent effector responses. These results newly identify a key role for OX40 in the homeostasis of intestinal Foxp3+ T reg cells and in suppression of colitis. These fi ndings should be taken into account when considering OX40 blockade for treatment of IBD.
Figures
References
- Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., Ochs H.D. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20–21 10.1038/83713
- Bouma G., Strober W. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3:521–533 10.1038/nri1132
- Cederbom L., Hall H., Ivars F. 2000. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30:1538–1543 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>;2-X
- Chaudhry A., Rudra D., Treuting P., Samstein R.M., Liang Y., Kas A., Rudensky A.Y. 2009. CD4+ Regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. 326:986–991
- Chen Q., Davidson T.S., Huter E.N., Shevach E.M. 2009. Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival. J. Immunol. 183:4458–4466 10.4049/jimmunol.0901465
- Coombes J.L., Robinson N.J., Maloy K.J., Uhlig H.H., Powrie F. 2005. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204:184–194 10.1111/j.0105-2896.2005.00250.x
- Croft M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3:609–620 10.1038/nri1148
- Darrasse-Jèze G., Deroubaix S., Mouquet H., Victora G.D., Eisenreich T., Yao K.H., Masilamani R.F., Dustin M.L., Rudensky A., Liu K., Nussenzweig M.C. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206:1853–1862 10.1084/jem.20090746
- Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329–341 10.1016/j.immuni.2005.01.016
- Golovina T.N., Mikheeva T., Suhoski M.M., Aqui N.A., Tai V.C., Shan X., Liu R., Balcarcel R.R., Fisher N., Levine B.L., et al. 2008. CD28 costimulation is essential for human T regulatory expansion and function. J. Immunol. 181:2855–2868
- Hippen K.L., Harker-Murray P., Porter S.B., Merkel S.C., Londer A., Taylor D.K., Bina M., Panoskaltsis-Mortari A., Rubinstein P., Van Rooijen N., et al. 2008. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood. 112:2847–2857 10.1182/blood-2008-01-132951
- Ito T., Wang Y.H., Duramad O., Hori T., Delespesse G.J., Watanabe N., Qin F.X., Yao Z., Cao W., Liu Y.J. 2005. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202:1213–1223 10.1084/jem.20051135
- Izcue A., Hue S., Buonocore S., Arancibia-Cárcamo C.V., Ahern P.P., Iwakura Y., Maloy K.J., Powrie F. 2008. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity. 28:559–570 10.1016/j.immuni.2008.02.019
- Izcue A., Coombes J.L., Powrie F. 2009. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27:313–338 10.1146/annurev.immunol.021908.132657
- Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10:595–602 10.1038/ni.1731
- Malmström V., Shipton D., Singh B., Al-Shamkhani A., Puklavec M.J., Barclay A.N., Powrie F. 2001. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J. Immunol. 166:6972–6981
- Maloy K.J., Salaun L., Cahill R., Dougan G., Saunders N.J., Powrie F. 2003. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111–119 10.1084/jem.20021345
- Onishi Y., Fehervari Z., Yamaguchi T., Sakaguchi S. 2008. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA. 105:10113–10118 10.1073/pnas.0711106105
- Pfaffl M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45 10.1093/nar/29.9.e45
- Piconese S., Valzasina B., Colombo M.P. 2008. OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J. Exp. Med. 205:825–839 10.1084/jem.20071341
- Pippig S.D., Peña-Rossi C., Long J., Godfrey W.R., Fowell D.J., Reiner S.L., Birkeland M.L., Locksley R.M., Barclay A.N., Killeen N. 1999. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J. Immunol. 163:6520–6529
- Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., Coffman R.L. 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity. 1:553–562 10.1016/1074-7613(94)90045-0
- Ruby C.E., Montler R., Zheng R., Shu S., Weinberg A.D. 2008. IL-12 is required for anti-OX40-mediated CD4 T cell survival. J. Immunol. 180:2140–2148
- Sakaguchi S., Yamaguchi T., Nomura T., Ono M. 2008. Regulatory T cells and immune tolerance. Cell. 133:775–787 10.1016/j.cell.2008.05.009
- Sather B.D., Treuting P., Perdue N., Miazgowicz M., Fontenot J.D., Rudensky A.Y., Campbell D.J. 2007. Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204:1335–1347 10.1084/jem.20070081
- Shevach E.M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 30:636–645 10.1016/j.immuni.2009.04.010
- Shevach E.M., Stephens G.L. 2006. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat. Rev. Immunol. 6:613–618 10.1038/nri1867
- Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135–142 10.1038/ni759
- Song J., So T., Cheng M., Tang X., Croft M. 2005. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity. 22:621–631 10.1016/j.immuni.2005.03.012
- Souza H.S., Elia C.C., Spencer J., MacDonald T.T. 1999. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 45:856–863
- Sugamura K., Ishii N., Weinberg A.D. 2004. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat. Rev. Immunol. 4:420–431 10.1038/nri1371
- Takeda I., Ine S., Killeen N., Ndhlovu L.C., Murata K., Satomi S., Sugamura K., Ishii N. 2004. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol. 172:3580–3589
- Tang Q., Adams J.Y., Penaranda C., Melli K., Piaggio E., Sgouroudis E., Piccirillo C.A., Salomon B.L., Bluestone J.A. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 28:687–697 10.1016/j.immuni.2008.03.016
- Valzasina B., Guiducci C., Dislich H., Killeen N., Weinberg A.D., Colombo M.P. 2005. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood. 105:2845–2851 10.1182/blood-2004-07-2959
- van Olffen R.W., Koning N., van Gisbergen K.P., Wensveen F.M., Hoek R.M., Boon L., Hamann J., van Lier R.A., Nolte M.A. 2009. GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J. Immunol. 182:7490–7500 10.4049/jimmunol.0802751
- Vu M.D., Xiao X., Gao W., Degauque N., Chen M., Kroemer A., Killeen N., Ishii N., Chang Li X. 2007. OX40 costimulation turns off Foxp3+ Tregs. Blood. 110:2501–2510 10.1182/blood-2007-01-070748
- Wan Y.Y., Flavell R.A. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature. 445:766–770 10.1038/nature05479
- Watts T.H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23:23–68 10.1146/annurev.immunol.23.021704.115839
- Yuan Q., Bromley S.K., Means T.K., Jones K.J., Hayashi F., Bhan A.K., Luster A.D. 2007. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J. Exp. Med. 204:1327–1334 10.1084/jem.20062076
- Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.T., Corcoran L., Treuting P., Klein U., Rudensky A.Y. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature. 458:351–356 10.1038/nature07674
Source: PubMed